Differential effects of ecstasy on short-term and working memory: A meta-analysis

Neuropsychology Review

Volumn 20, Issue 1, 2010, Pages 33-51

  Nulsen, Claire E ^a   Fox, Allison M ^a   Hammond, Geoffrey R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Ecstasy; Memory; Short term memory; Working memory

Indexed keywords

EID: 77953288348     PISSN: 10407308     EISSN: 15736660     Source Type: Journal    
DOI: 10.1007/s11065-009-9110-5     Document Type: Review

References (83)

1. Back-Madruga, C., Boone, K. B., Chang, L., Grab, C. S., Lee, A., Nations, H., et al. (2003). Neuropsychological effects of 3,4- methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clinical Neuropsychologist, 17, 446-459.
2. Bedi, G., & Redman, J. (2008). Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds. Psychological Medicine, 38, 1319-1330.
3. Bhattechary, S., & Powell, J. H. (2001). Recreational use of 3, 4-methylenedioxymethamphetemine (MDMA) or 'ecstasy': evidence for cognitive impairment. Psychological Medicine, 31, 647-658.
4. Cantor, J., Engle, R. W., & Hamilton, G. (1991). Short-term memory, working memory, and verbal abilities: how do they relate? Intelligence, 15, 229-246.
5. Capela, J. P., Carmo, H., Femião, F., Bastos, M. L., Meisel, A., & Carvalho, F. (2009). Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Molecular Neurobiology, 39, 210-271.
6. Cohen, J. (1969). Statistical power analysis for the behavioral sciences. NY: Academic Press.
7. Cole, J. C., Michailidou, K., Jerome, L., & Sumnall, H. R. (2006). The effects of stereotype threat on cognitive function in ecstasy users. Journal of Psychopharmacology, 20, 518-525.
8. Conway, A. R. A., Cowan, N., Bunting, M. F., Therriault, D. J., & Minkoff, S. R. B. (2002). A latent variable analysis of working memory capacity, short-term memory capacity, processing speed, and general, fluid intelligence. Intelligence, 30, 163-183.
9. Croft, R. J., Mackay, A. J., Mills, A. T. D., & Gruzelier, J. G. H. (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 153, 373-379.
10. Curran, H. V. (2000). Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology, 42, 34-41.
11. Dafters, R. I. (2006). Chronic ecstasy (MDMA) use is associated with deficits in taskswitching but not inhibition or memory updating executive functions. Drug and Alcohol Dependence, 83, 181-184.
12. Daumann, J., Schnitker, R., Weidemann, J., Schnell, K., Thron, A., & Gouzoulis-Mayfrank, E. (2003). Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users. NeuroReport, 14, 1983-1987.
13. de Sola, S., Tarancón, T., Peña-Casanova, J., Espadaler, J. M., Langohr, K., Poudevida, S., et al. (2008). Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Psychopharmacology, 200, 425-437.
14. de Sola Llopis, S., Miguelez-Pan, M., Peña-Casanova, J., Poudevida, S., Farré, M., Pacifici, R., et al. (2008). Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. Journal of Psychopharmacology, 22, 498-510.
15. D'Esposito, M., Postle, B. R., Ballard, D., & Lease, J. (1.999). Maintenance versus manipulation of information held in working memory: An event-related fMRI study. Brain and Cognition, 41, 66-86.
16. Della Sala, S., Gray, C., Baddeley, A., Allamano, N., & Wilson, L. (1999). Pattern span: A tool for unwelding visuo-spatial memory. Neuropsychologia, 37, 1189-1199.
17. Engle, R. W., Tuholski, S. W., Laughlin, J. E., & Conway, A. R. A. (1999). Working memory, short-term memory, and general fluid intelligence: a latent-variable approach. Journal of Experimental Psychology: General, 128, 309-331.
18. Fisk, J. E., & Montgomery, C. (2009). Evidence for selective executive function deficits in ecstesy/polydrug users. Journal of Psychopharmacology, 23, 40-50.
19. Fisk, J. E., Montgomery, C., Murphy, P., & Wareing, M. (2004). Evidence for executive deficits among users of MDMA (Ecstasy). British Journal of Psychology, 95, 457-466.
20. Fox, H. C., Parrott, A. C., & Turner, J. J. D. (2001). Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. Journal of Psychopharmacology, 15, 273-281.
21. Fox, H. C., McLean, A., Turner, J. J. D., Parrott, A. C., Rogers, R., & Sahakian, B. J. (2002). Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy" ) polydrug users. Psychopharmacology, 162, 203-214.
22. Golding, J. F., Groome, D. H., Rycroft, N., & Denton, Z. (2007). Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls. The American Journal of Drug and Alcohol Abuse, 33, 301-307.
23. Gouzoulis-Mayfrank, E., Daumann, J., Tuchtenhagen, F., Pelz, S., Becker, S., Kunert, H-J., et al. (2000). Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery & Psychiatry, 68, 719-725.
24. Gouzoulis-Mayfrank, E., Thimm, B., Rezk, M., Hensen, G., & Daumann, J. (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuropsychopharmacology & Biological Psychiatry, 27, 819-827.
25. Green, A. R., Mechan, A. O., Elliott, J. M., O'Shea, E., & Colado, I. (2003). The pharmacology and clinical pharmacology of 3, 4- methylenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacological Reviews, 55, 463-508.
26. Halpern, J. H., Pope, H. G., Jr., Sherwood, A. R., Barry, S., Hudson, J. I., & Yurgelun-Todd, D. (2004). Residual neuropsychological effects of illicit 3, 4-methylenedioxymethamphetomine (MDMA) in individuals with minimal exposure to other drugs. Drug and Alcohol Dependence, 75, 135-147.
27. Hanson, K. L., & Luciana, M. (2004). Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Psychological Medicine, 34, 229-246.
28. Hatzidimitriou, G., McCann, U. D., & Ricaurte, G. A. (1999). Altered serotonin innervation patterns in the forebrain of monkeys treated with (6)3, 4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. The Journal of Neuroscience, 19, 5096-5107.
29. Heffernan, T., Jarvis, H., Rodgers, J., Scholey, A. B., & Ling, J. (2001). Prospective memory, everyday cognitive failure and central executive function in recreational users of ecstasy. Human Psychopharmacology: Clinical and Experimental, 16(8), 607-612.
30. Kalechstein, A. D., De La Garza, R., II, Mahoney, J. J., III, Fantegrossi, W. E., & Newton, T. F. (2007). MDMA use and neurocognition: a meta-analytic review. Psychopharmacology, 189, 531-531.
31. Kessels, R. P. C., van den Berg, E., Ruis, C., & Brands, A. M. A. (2008). The backward, span of the Corsi block-topping task and its association with the WAIS-III digit span. Assessment, 15, 426-434.
32. Kirchner, W K. (1958). Age differences in short-term retention of rapidly changing information. Journal of Experimental Psychology, 55, 352-358.
33. Lamers, C. T. J., Bechara, A., Rizzo, M., & Ramaekers, J. G. (2006). Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. Journal of Psychopharmacology, 20, 302-311.
34. Lau, J., Ioannidis, J. P. A., & Schmid, C. H. (1997). Quantitative synthesis in systematic reviews. Annals of Internal Medicine, 127, 820-826.
35. Laws, K. R., & Kokkalis, J. (2007). Ecstasy (MDMA) and memory function: a meta-analytic update. Human Psychopharmacology: Clinical and Experimental, 22, 381-388.
36. Lezak, M. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.
37. Luciana, M., Collins, P. F., & Depue, R. A. (1998). Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex, 8, 218-226.
38. Luciana, M., Burgund, E. D., Berman, M., & Hanson, K. L. (2001). Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults. Journal of Psychopharmacology, 15, 219-230.
39. McCann, U. D., Eligulashvili, V., & Ricaurte, G. A. (2000). (±)3, 4-metliylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology, 42, 11-16.
40. McCann, U. D., Mertl, M., Eligulashvili, V., & Ricaurte, G. A. (1999). Cognitive performance in (=) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology, 143, 417-425.
41. McCann, U. D., Peterson, S. C., & Ricaurte, G. A. (2007). The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacology, 32, 1695-1706.
42. McCardle, K., Luebbers, S., Carter, J. D., Croft, R. J., & Stough, C. (2004). Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology, 173, 434-439.
43. Medina, K. L., Shear, P. K., & Corcoran, K. (2005). Ecstasy (MDMA) exposure and neuropsychological functioning: A polydrug perspective. Journal of the International Neuropsychological Society, 11, 753-765.
44. Montgomery, C., & Fisk, J. E. (2007). Everyday memory deficits in ecstesy-polydrug users. Journal of psychopharmacology, 21(1), 709-717.
45. Montgomery, C., & Fisk, J. E. (2008). Ecstasy-related deficits in the updating component of executive processes. Human Psychopharmacology: Clinical and Experimental, 23, 495-511.
46. Montgomery, C., Fisk, J. E., Newcombe, R., Wareing, M., & Murphy, P. N. (2005). Syllogistic reasoning performance in MDMA (Ecstasy) users. Experimental and Clinical Psychopharmacology, 13, 137-145.
47. Morgan, M. J. (1.998). Recreational, use of 'ecstasy' (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19, 252-264.
48. Morgan, M. J. (1999). Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology, 141, 30-36.
49. Morgan, M. J. (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology, 153, 230-248.
50. Owen, A. M. (1997). The functional organization of working memory processes within human lateral frontal cortex: the contribution of functional neuroimaging. European Journal of Neuroscience, 9, 1329-1339.
51. Park, D. C., Lautenschlager, G., Hedden, T., Davidson, N. S., Smith, A. D., & Smith, P. K. (2002). Models of visuospatial and verbal memory across the adult life span. Psychology and Aging, 17(2), 299-320.
52. Parrott, A. C., Lees, A., Garnham, N. J., Jones, M., & Wesnes, K. (1998). Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits. Journal of Psychopharmacology, 12, 79-83.
53. Pereira, A. P. A. (2007). Assessment of memory in rehabilitation counselling. Journal of Rehabilitation, 73, 15-25.
54. Pollack, I., Johnson, L. B., & Knaff, P. R. (1959). Running memory span. Journal of Experimental Psychology, 57, 137-146.
55. Quednow, B. B., Jessen, F., Kühn, K.-U., Maier, W., Daum, I., & Wagner, M. (2006). Memory deficits in abstinent MDMA (ecstasy) users: Neuropsychological evidence of frontal, dysfunction. Journal of Psychopharmacology, 20, 373-384.
56. Reay, J. L., Hamilton, C., Kennedy, D. O., & Scholey, A. B. (2006). MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. Journal of Psychopharmacology, 20, 385-388.
57. Reneman, L., Booij, J., Schmand, B., van den Brink, W., & Gunning, B. (2000). Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology, 148, 322-324.
58. Reneman, L., Lavalaye, J., Schmand, B., de Wolff, F., van den Brink, W., den Heeten, G., et al. (2001a). Cortical serotonin transporter density and verbal memory in individuals who stopped using 3, 4- methylenedioxymethamphetamine (MDMA or "Ecstasy"): Preliminary findings. Archives of General Psychiatry, 58, 901-906.
59. Reneman, L., Majoie, C. B. L. M., Schmand, B., van den Brink, W., & den Heeten, G. J. (2001b). Prefrontal N-acetylaspartate is strongly associated, with memory performance in (abstinent) ecstasy users: preliminary report. Biological Psychiatry, 50, 550-554.
60. Reneman, L., Schilt, T., de Win, M. M., Booij, J., Schmand, B., van den Brink, W., et al. (2006). Memory function and serotonin transporter promoter gene polymorphism, in ecstasy (MDMA) users. Journal of Psychopharmacology, 20, 389-399.
61. Repovs, G., & Baddeley, A. (2006). The multi-component model of working memory: explorations in experimental, cognitive psychology. Neuroscience, 139, 5-21.
62. Richardson, J. T. E. (2007). Measures of short-term memory: a historical review. Cortex, 43, 635-650.
63. Rodgers, J. (2000). Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology, 151, 19-24.
64. Roiser, J. P., Rogers, R. D., & Sahakian, B. J. (2007). Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology, 189, 505-516.
65. Rosenthal, R. (1979). The "file drawer problem" and tolerance for null results. Psychological Bulletin, 86, 638-641.
66. Schifano, F., Di Furia, L., Forza, G., Minicuci, N., & Bricolo, R. (1998). MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. Drug and Alcohol Dependence, 52, 85-90.
67. Schilt, T., De Win, M. M., Koeter, M., Jager, G., Korf, D. J., van den Brink, W., et al. (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry, 64, 728-736.
68. Thomasius, R., Zapletalova, P., Petersen, K., Buchert, R., Andresen, B., Wartberg, L., et al. (2006). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Journal of Psychopharmacology, 20, 211-225.
69. Verbaten, M. N. (2003). Specific memory deficits in ecstasy users? The results of a meta-analysis. Human Psychopharmacology: Clinical and Experimental, 18, 281-290.
70. Verkes, R. J., Gijsman, H. J., Pieters, M. S. M., Schoemaker, R. C., de Visser, S., Kuijpers, M., et al. (2001). Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology, 153, 196-202.
71. von Geusau, N. A., Stalenhoef, P., Huizinga, M., Snel, J., & Ridderinkof, K. R. (2004). Impaired, executive function in male MDMA ("ecstasy") users. Psychopharmacology, 175, 331-341.
72. Wager, T. D., & Smith, E. E. (2003). Neuroimaging studies of working memory: a meta-analysis. Cognitive, Affective, & Behavioral Neuroscience, 3, 255-274.
73. Wareing, M., Fisk, J. E., & Murphy, P. N. (2000). Working memory deficits in current and previous users of MDMA ('ecstasy'). British Journal of Psychology, 91, 181-188.
74. Wareing, M., Fisk, J. E., Murphy, P., & Montgomery, C. (2004a). Verbal working memory deficits in current and previous users of MDMA. Human Psychopharmacology: Clinical and Experimental, 19, 225-234.
75. Wareing, M., Murphy, P. N., & Fisk, J. E. (2004b). Visuospatial memory impairments in users of MDMA ('ecstasy'). Psychopharmacology, 173, 391-397.
76. Wareing, M., Fisk, J. E., Murphy, P., & Montgomery, C. (2005). Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy'). Human Psychopharmacology: Clinical and Experimental, 20, 115-123.
77. Wareing, M., Fisk, J. E., Montgomery, C., Murphy, P. N., & Chandler, M. D. (2007). Information processing speed in ecstasy (MDMA) users. Human Psychopharmacology: Clinical and Experimental, 22, 81-88.
78. Yip, J. T. H., & Lee, T. M. C. (2005). Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology, 179, 620-628.
79. Zakzanis, K. K., & Young, D. A. (2001). Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation. Neurology, 56, 966-969.
80. Zakzanis, K. K., & Campbell, Z. (2006). Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up. Neurology, 66(5), 740-741.
81. Zakzanis, K. K., Young, D. A., & Campbell, Z. (2003). Prospective memory impairment in abstinent MDMA ("Ecstasy") users. Cognitive Neuropsychiatry, 8(2), 141-153.
82. Zakzanis, K. K., Campbell, Z., & Jovanovski, D. (2007). The neuropsychology of ecstasy (MDMA) use: a quantitative review. Human Psychopharmacology: Clinical and Experimental, 22, 427-435.
83. Zaninotto, A. L. C., Bueno, O. F. A., Pradella-Hallinan, M., Tufik, S., Rusted, J., Stough, C., et al. (2009). Acute cognitive effects of donepezil in young, healthy volunteers. Human Psychopharmacology: Clinical and Experimental, 24, 453-464.